Here is who you can expect to meet this Fall!


2019 Attendee list as of October 7 below:


Organization, Title and Department

Acceleron Pharma Inc, VP Medical Research, Medical Research
Alkem Labs Ltd, Deputy Manager, Portfolio Planning & API Project Management
Amgen Inc, Director Business Performance, Business Performance
Amgen Inc, Executive Director Business Performance, Business Performance
Amgen Inc, Director Clinical Study Planning, Clinical Study Planning
Astellas Pharma Inc, Associate Director, Product & Portfolio Strategy
Astellas Pharma US Inc, Director, Strategy
Bayer HealthCare Pharmaceuticals, Executive & Program Head Immuno Oncology, Oncology R&D
BeiGene, Chief of Staff & Head, Immuno Oncology & Project Management
Berg LLC, Sr VP & CSO
BioMarin Pharmaceutical Inc, Sr Director Portfolio & Program Management, Portfolio & Planning Management
BioMarin Pharmaceutical Inc, Manager Portfolio Analysis, Portfolio Analysis
BioMarin Pharmaceutical Inc, Sr Director, Scientific Strategy & Discovery Portfolio
BioMarin Pharmaceutical Inc, Associate, TOPS PMO
Blackstone Life Sciences, Sr Advisor
bluebird bio, Director, Program Management
bluecrux, Management Consultant, Binocs Resource Planning in Life Sciences
bluecrux, Founder & CEO
Boehringer Ingelheim Pharma GmbH & Co KG, Sr Manager, Technology & Innovation & Biologics Development
Bristol Myers Squibb Co, Associate Director, Commercial Products
Bristol Myers Squibb Co, Project Management Lead, Innovative Medicines Development
Bristol Myers Squibb Co, Associate Director, Integrated Oncology Strategy and Operations
Bristol Myers Squibb Co, Associate Director Project Management, Integrated Oncology Strategy and Operations
Bristol Myers Squibb Co, Head, R&D Business Capabilities
Bristol Myers Squibb Co, Sr Business Capability Analyst, R&D Strategy & Planning
Bristol Myers Squibb Co, Project Manager, Strategy & Portfolio Management
Bristol Myers Squibb Co, Director US Oncology Operations, US Oncology Operations
Captario, VP Product Management
Celgene Corp, Associate Director Strategic Operations, Global Clinical Development
Celgene Corp, Director Strategic Operations, Global Clinical R&D
Cell Signaling Technology Inc, Sr Portfolio & Project Manager, Product Development
CKD Pharma, Sr Research Scientist
Context Therapeutics, Co Founder & CEO
CSL Behring, Manager, Breakthrough Technologies
CSL Behring, Director Portfolio Management & Governance, Portfolio Management & Governance
Cybrexa Therapeutics, VP Marketing, Marketing
Daiichi Sankyo Inc, Sr Director Project & Portfolio Management, Global Project Management & Leadership
Daiichi Sankyo Inc, Associate Director Project & Portfolio Management, Project & Portfolio Management
Eli Lilly & Co, Sr Research Advisor, Portfolio Strategy & Decision Sciences
Eli Lilly & Co, Director Strategy & Business Development & Oncology, Strategy & Business Development & Oncology
EMD Serono R&D, Global Project Planner Strategy & Business Ops, Integrated Planning & Analytics & Partnering
Enrich Consulting Inc, Analyst
Enrich Consulting Inc, Associate Director
Enrich Consulting Inc, President & CEO
Erytech PharmaSA, Program Manager
Exelixis Inc, Executive Director Biologics & Biotherapeutics, Biologics & Biotherapeutics
Five Prime Therapeutics Inc, Executive Director, FP&A
Five Prime Therapeutics Inc, Sr Director Project Management, Project Management
Galapagos NV, Sr Portfolio & Alliance Manager & Associate Director
Genentech Inc, Pipeline and Portfolio Planning, Translational Medicine
GlaxoSmithKline, Director Strategy & Operations & Planning, Cell & Gene Therapy
GlaxoSmithKline, Sr Director & Head, Portfolio Capability Development & Innovation
GlaxoSmithKline, Director Portfolio Decision Sciences, Portfolio Decision Sciences
GlaxoSmithKline, Director Preclinical R&D Safety Assesment, Preclinical R&D Safety Assesment
GlaxoSmithKline, Oncology Pipeline Project Director, R&D
GlaxoSmithKline, Project Manager, R&D
GlaxoSmithKline, Sr Director Portfolio Governance & Head, TA Portfolio Management
Grant Thornton LLP, Principal, Advisory Services
Grant Thornton LLP, Managing Director Business Consulting, Life Sciences
Grant Thornton LLP, Director
Halozyme Therapeutics, Director Project Management, Project Management
I Mab Biopharma Co Ltd, Executive Director, Portfolio & Project Management
ImmunoRestoration, CCO
Institut De Recherches Internationales Servier, Deputy Director, R&D Portfolio Management
Intelligencia.ai, Executive Director
IQVIA, Vice President, Consulting
IQVIA, Enterprise Software Product Manager, Consulting Services
IQVIA, Consulting Services
IQVIA, Sr Software Solutions Principal
Janssen Pharmaceuticals Inc, Sr Manager, Capacity Management
Janssen Pharmaceuticals Inc, Associate Director Project Management, Project Management
Janssen R&D LLC, Sr Manager, Capacity Management
Janssen R&D LLC, IT Director Clinical Decision Support, Clinical Decision Support
Janssen R&D LLC, Director Advanced Analytics, R&D
Jiangsu Alphamab Biopharmaceuticals Co Ltd, CMO
JR Simplot Co, Project Manager, Biotech
Keck Graduate Institute, Graduate Student
Kite Pharma, Program & Portfolio Manager
Kite Pharma Inc, Program Manager, CMC Management
Kite Pharma Inc, Sr Manager, CMC Management & Strategy & Business Operations
Kite Pharma Inc, Sr Manager, CMC Performance & Analytics
Leukemia & Lymphoma Society, Head, Clinical Operations Beat AML
Maverick Therapeutics Inc, Sr Director Program & Alliance Management, Program & Alliance Management
Meiji Seika Pharma Co Ltd, Assistant Manager, Project Management Office
Merck, Associate Director Global Regulatory Affairs & Clin Safety, Global Regulatory Affairs & Clinical Safety
Merck, Director Project Management, Project Management
Merck & Co, Executive Director Corp Licensing, Oncology Transactions Business Development & Licensing
Merck & Co, VP & Head Global Portfolio Management, Valuation & Analytics
Merck KGaA, Sr Strategic R&D Operations Analyst, Integrated Planning Analytics & Partnering
Merck Research Labs, Business Operations Lead, Global Regulatory Affairs & Clinical Safety
Mirati Therapeutics, Executive VP & CBO
Molecular Partners AG, Director Downstream Processing, Development
MPM Capital LLC, Managing Director
Novartis Institutes for BioMedical Research Inc, Executive Director & Head Search & Evaluation, Business Development & Licensing
Novartis Pharmaceuticals, Director Portfolio Management, Oncology Business Unit
ORbee Consulting, Founder & President
Osage University Partners, Partner
Oxford Nanoimaging Ltd, Business Development Leads
Pfenex, Director, Portfolio Strategy
Pfizer Inc, Principal, Pfizer Ventures
Pharmica Consulting, Owner & Partner
Pharmica Consulting, Partner
Planisware, VP Life Sciences, Life Sciences PPM
Planisware, Director Life Sciences, PPM Practice
Planisware, Presales Engineer, Presales
Radius Health Inc, CMO
Regeneron Pharmaceuticals Inc, Management Associate II, Development Program Management
Rosa & Co LLC, Chief Engineer, PhysioPD
Shanghai Henlius Biotech Co Ltd, Sr Manager, Strategy & Portfolio Management
Taiho Pharmaceutical Co, Associate Director, Corporate Planning
Taiho Pharmaceutical Co, Deputy Director, Proj Management Office
Taiho Pharmaceutical Co, Project Manager, Proj Management Office
Taiho Pharmaceutical Co, Manager, Strategic Portfolio Office
Takeda, Head, Business Operations
Thomas Jefferson University, Sr Director, Early Drug Development Office
Tmunity Therapeutics Inc, CMO
Uplifting Athletes, Executive Director
US Dept of Health & Human Services, Pharmaceutical Portfolio Manager
Zinata, Advisory Board Member, Business Development
ZS Associate, Associate Partner, Strategy Insights & Planning

Download Brochure

For more details on the conference, please contact:

Bridget Kotelly
Senior Conference Director
Cambridge Healthtech Institute
Phone: (+1) 781-972-5404
Email:
bkotelly@cambridgeinnovationinstitute.com


Program and Portfolio Management